(GENI) Genius Sports - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: GG00BMF1JR16
Stock: Data Collection, Integrity Services, Streaming Solutions, Betting Technology
Total Rating 34
Risk 29
Buy Signal -1.39
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 114% |
| Relative Tail Risk | -9.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -52.60 |
| Character TTM | |
|---|---|
| Beta | 1.205 |
| Beta Downside | 1.496 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.06% |
| CAGR/Max DD | 0.13 |
Description: GENI Genius Sports January 12, 2026
Genius Sports Ltd (NYSE:GENI) builds and sells technology-driven products to sports leagues, betting operators, and media firms. Its core offerings include a data-collection and distribution platform that streams live match statistics, automated video-production and streaming services that monetize game footage, and an integrity suite that uses algorithmic monitoring to flag suspicious betting patterns, complemented by consulting and education services.
Key recent metrics underscore the company’s growth trajectory: FY 2023 revenue reached $215 million, up ~22 % YoY, driven largely by expanding contracts with major European football leagues and a 15 % increase in streaming-service ARR. The sports-betting data market is projected to grow at a 12 % CAGR through 2028, while regulatory tightening in the U.S. and Europe is boosting demand for integrity solutions-both of which are primary economic tailwinds for GENI.
For a deeper quantitative assessment of GENI’s valuation metrics, the ValueRay platform offers a concise dashboard of forward-looking financials and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -119.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 7.90 > 1.0 |
| NWC/Revenue: 32.61% < 20% (prev 16.28%; Δ 16.33% < -1%) |
| CFO/TA 0.08 > 3% & CFO 84.1m > Net Income -119.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (257.7m) vs 12m ago 10.24% < -2% |
| Gross Margin: 21.92% > 18% (prev 0.20%; Δ 2172 % > 0.5%) |
| Asset Turnover: 68.15% > 50% (prev 63.81%; Δ 4.35% > 0%) |
| Interest Coverage Ratio: -628.8 > 6 (EBITDA TTM -70.9m / Interest Expense TTM 218.0k) |
Altman Z'' -7.41
| A: 0.19 (Total Current Assets 466.4m - Total Current Liabilities 269.3m) / Total Assets 1.05b |
| B: -1.12 (Retained Earnings -1.18b / Total Assets 1.05b) |
| C: -0.15 (EBIT TTM -137.1m / Avg Total Assets 887.0m) |
| D: -3.76 (Book Value of Equity -1.23b / Total Liabilities 326.6m) |
| Altman-Z'' Score: -7.41 = D |
Beneish M -3.15
| DSRI: 1.11 (Receivables 186.1m/128.8m, Revenue 604.5m/462.5m) |
| GMI: 0.91 (GM 21.92% / 19.84%) |
| AQI: 0.76 (AQ_t 0.50 / AQ_t-1 0.66) |
| SGI: 1.31 (Revenue 604.5m / 462.5m) |
| TATA: -0.19 (NI -119.2m - CFO 84.1m) / TA 1.05b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of GENI shares?
As of February 07, 2026, the stock is trading at USD 6.09 with a total of 22,559,782 shares traded.
Over the past week, the price has changed by -30.00%, over one month by -42.33%, over three months by -40.35% and over the past year by -33.73%.
Over the past week, the price has changed by -30.00%, over one month by -42.33%, over three months by -40.35% and over the past year by -33.73%.
Is GENI a buy, sell or hold?
Genius Sports has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy GENI.
- StrongBuy: 11
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GENI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.6 | 155.8% |
| Analysts Target Price | 15.6 | 155.8% |
| ValueRay Target Price | 6 | -1.6% |
GENI Fundamental Data Overview February 04, 2026
P/E Forward = 90.0901
P/S = 3.3131
P/B = 3.0561
Revenue TTM = 604.5m USD
EBIT TTM = -137.1m USD
EBITDA TTM = -70.9m USD
Long Term Debt = 30.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.08m USD (from shortTermDebt, last quarter)
Debt = 30.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -177.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.83b USD (2.00b + Debt 30.2m - CCE 207.8m)
Interest Coverage Ratio = -628.8 (Ebit TTM -137.1m / Interest Expense TTM 218.0k)
EV/FCF = 81.26x (Enterprise Value 1.83b / FCF TTM 22.5m)
FCF Yield = 1.23% (FCF TTM 22.5m / Enterprise Value 1.83b)
FCF Margin = 3.72% (FCF TTM 22.5m / Revenue TTM 604.5m)
Net Margin = -19.71% (Net Income TTM -119.2m / Revenue TTM 604.5m)
Gross Margin = 21.92% ((Revenue TTM 604.5m - Cost of Revenue TTM 472.0m) / Revenue TTM)
Gross Margin QoQ = 24.65% (prev 7.49%)
Tobins Q-Ratio = 1.74 (Enterprise Value 1.83b / Total Assets 1.05b)
Interest Expense / Debt = 0.46% (Interest Expense 138.0k / Debt 30.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -108.3m (EBIT -137.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.73 (Total Current Assets 466.4m / Total Current Liabilities 269.3m)
Debt / Equity = 0.04 (Debt 30.2m / totalStockholderEquity, last quarter 722.5m)
Debt / EBITDA = 2.50 (negative EBITDA) (Net Debt -177.6m / EBITDA -70.9m)
Debt / FCF = -7.91 (Net Debt -177.6m / FCF TTM 22.5m)
Total Stockholder Equity = 681.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -13.44% (Net Income -119.2m / Total Assets 1.05b)
RoE = -17.49% (Net Income TTM -119.2m / Total Stockholder Equity 681.5m)
RoCE = -19.26% (EBIT -137.1m / Capital Employed (Equity 681.5m + L.T.Debt 30.2m))
RoIC = -15.89% (negative operating profit) (NOPAT -108.3m / Invested Capital 681.5m)
WACC = 10.21% (E(2.00b)/V(2.03b) * Re(10.36%) + D(30.2m)/V(2.03b) * Rd(0.46%) * (1-Tc(0.21)))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.43%
[DCF Debug] Terminal Value 60.95% ; FCFF base≈22.5m ; Y1≈14.7m ; Y5≈6.73m
Fair Price DCF = 1.14 (EV 95.5m - Net Debt -177.6m = Equity 273.1m / Shares 238.7m; r=10.21% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 29.96 | EPS CAGR: 11.24% | SUE: -0.45 | # QB: 0
Revenue Correlation: 84.25 | Revenue CAGR: 19.97% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.42 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+40.0% | Growth Revenue=+20.9%
P/S = 3.3131
P/B = 3.0561
Revenue TTM = 604.5m USD
EBIT TTM = -137.1m USD
EBITDA TTM = -70.9m USD
Long Term Debt = 30.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.08m USD (from shortTermDebt, last quarter)
Debt = 30.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -177.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.83b USD (2.00b + Debt 30.2m - CCE 207.8m)
Interest Coverage Ratio = -628.8 (Ebit TTM -137.1m / Interest Expense TTM 218.0k)
EV/FCF = 81.26x (Enterprise Value 1.83b / FCF TTM 22.5m)
FCF Yield = 1.23% (FCF TTM 22.5m / Enterprise Value 1.83b)
FCF Margin = 3.72% (FCF TTM 22.5m / Revenue TTM 604.5m)
Net Margin = -19.71% (Net Income TTM -119.2m / Revenue TTM 604.5m)
Gross Margin = 21.92% ((Revenue TTM 604.5m - Cost of Revenue TTM 472.0m) / Revenue TTM)
Gross Margin QoQ = 24.65% (prev 7.49%)
Tobins Q-Ratio = 1.74 (Enterprise Value 1.83b / Total Assets 1.05b)
Interest Expense / Debt = 0.46% (Interest Expense 138.0k / Debt 30.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -108.3m (EBIT -137.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.73 (Total Current Assets 466.4m / Total Current Liabilities 269.3m)
Debt / Equity = 0.04 (Debt 30.2m / totalStockholderEquity, last quarter 722.5m)
Debt / EBITDA = 2.50 (negative EBITDA) (Net Debt -177.6m / EBITDA -70.9m)
Debt / FCF = -7.91 (Net Debt -177.6m / FCF TTM 22.5m)
Total Stockholder Equity = 681.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -13.44% (Net Income -119.2m / Total Assets 1.05b)
RoE = -17.49% (Net Income TTM -119.2m / Total Stockholder Equity 681.5m)
RoCE = -19.26% (EBIT -137.1m / Capital Employed (Equity 681.5m + L.T.Debt 30.2m))
RoIC = -15.89% (negative operating profit) (NOPAT -108.3m / Invested Capital 681.5m)
WACC = 10.21% (E(2.00b)/V(2.03b) * Re(10.36%) + D(30.2m)/V(2.03b) * Rd(0.46%) * (1-Tc(0.21)))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.43%
[DCF Debug] Terminal Value 60.95% ; FCFF base≈22.5m ; Y1≈14.7m ; Y5≈6.73m
Fair Price DCF = 1.14 (EV 95.5m - Net Debt -177.6m = Equity 273.1m / Shares 238.7m; r=10.21% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 29.96 | EPS CAGR: 11.24% | SUE: -0.45 | # QB: 0
Revenue Correlation: 84.25 | Revenue CAGR: 19.97% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.42 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+40.0% | Growth Revenue=+20.9%